Online Inquiry
Cat.#: ACPP-1265
| Despition | EDG8 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1280 | SRPX2 Blocking Peptide (AC1280) | 250 µg | inquiry |
| ACPP-1520 | Mouse PSPN Protein (AC1520) | 5 µg | inquiry |
| ACPP-1445 | Human RAB4A Protein (AC1445) | 2 µg | inquiry |
| ACPP-1499 | Mouse RAPSN Protein (AC1499) | 5 µg | inquiry |
| ACPP-1694 | Mouse FGF 1 Protein, His (AC1694) | 5 µg | inquiry |
| ACPP-1090 | PAX5 Blocking Peptide (AC1090) | 250 µg | inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1689 | Human DUSP26 Protein (AC1689) | 5 µg | inquiry |
| ACPP-1671 | Human SPINT2 Protein, Sf9 (AC1671) | 2 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.